Generics Israel-based generics drug giant Teva Pharmaceutical Industries met analysts' forecasts, reporting fourth-quarter 2009 net profit of $379 million, or $0.42 per share, compared with a loss of $694 million or $0.88/share a year earlier. Annual non-GAAP net income and non-GAAP earnings per share were $3.0 billion and $3.37, up 22% and 11%, respectively, compared with the year ended 2008. Annual GAAP net income and EPS totaled $2.0 billion and $2.23, respectively, versus $609 million and $0.75 in 2008. 16 February 2010